Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. - Ehsan Irajizad; Ranran Wu; Jody V. Vykoukal; Eunice Murage; Rachelle Spencer; Jennifer B. Dennison; Stacy Moulder; Elizabeth Ravenberg; Bora Lim; Jennifer Litton; Debu Tripathy; Vicente Valero; et al. (Frontiers Artif. Intell., 2022)

Predicting pathological complete response to neoadjuvant systemic therapy for triple-negative breast cancers using deep learning on multiparametric MRIs. - Zijian Zhou; Beatriz E. Adrada; Rosalind P. Candelaria; Nabil A. Elshafeey; Medine Boge; Rania M. Mohamed; Sanaz Pashapoor; Jia Sun; Zhan Xu; Bikash Panthi; Jong Bum Son; Mary S. Guirguis; et al. (EMBC, 2023)